However, at the same time ARL4C also acts as a suppressor gene, inhibiting the progression of ovarian cancer [12], and, in addition, the overexpression of ARL4C enhances the sensitivity of the non-small cell lung cancer cells to the erlotinib [13]. The gene discussed is ARL4C; the disease is ovarian carcinoma.